Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Amylyx Pharmaceuticals Inc (AMLX)
NASDAQ:AMLX
RESEARCH TOOLSreports
Amylyx Pharmaceuticals Inc (AMLX) Ownership - Who Owns Amylyx Pharmaceuticals Inc?
432 Followers
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| May 16, 2024 | Daphne Quimi Director | Bought | $9400 |
| Mar 07, 2024 | Sold | $28829 | |
| Mar 07, 2024 | Justin B. Klee Co Ceo,director | Sold | $77407 |
| Mar 07, 2024 | Joshua B Cohen Co Ceo,director | Sold | $77407 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | Sold | $2309568 | |
| Mar 31, 2024 | Sold | $6930190 | |
| Mar 31, 2024 | Bought | $11569920 | |
| Mar 31, 2024 | Sold | $12456652 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,106,251 | Institution | 7.51% | 9,344,439 | |
| 4,601,266 | Institution | 6.77% | 8,420,317 | |
| 2,962,555 | Institution | 4.36% | 5,421,476 | |
| 2,239,895 | Institution | 3.29% | 4,099,008 | |
| 1,267,837 | Institution | 1.86% | 2,320,142 | |
| 1,150,221 | Institution | 1.69% | 2,104,904 | |
| 1,050,198 | Institution | 1.54% | 1,921,862 | |
| 1,043,516 | Institution | 1.53% | 1,909,634 | |
| 960,060 | Institution | 1.41% | 1,756,910 | |
| 846,240 | Institution | 1.24% | 1,548,619 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,601,266 | Institution | 6.77% | 8,420,317 | |
| 1,267,837 | Institution | 1.86% | 2,320,142 | |
| 831,462 | Institution | 1.22% | 1,521,575 | |
| 594,415 | Institution | 0.87% | 1,087,779 | |
| 577,388 | Institution | 0.85% | 1,056,620 | |
| 537,478 | Institution | 0.79% | 983,585 | |
| 503,510 | Institution | 0.74% | 921,423 | |
| 469,920 | Institution | 0.69% | 859,954 | |
| 446,592 | Institution | 0.66% | 817,263 | |
| 430,997 | Institution | 0.63% | 788,725 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,811,143 | Institution | 2.66% | 3,278,169 | |
| 1,465,146 | Institution | 2.15% | 2,651,914 | |
| 1,200,858 | Institution | 1.77% | 2,197,570 | |
| 981,226 | Institution | 1.44% | 1,795,644 | |
| 828,052 | Institution | 1.22% | 1,498,774 | |
| 600,395 | Institution | 0.88% | 1,086,715 | |
| 431,969 | Institution | 0.64% | 790,503 | |
| 387,471 | Institution | 0.57% | 709,072 | |
| 387,802 | Institution | 0.57% | 652,877 | |
| 14,885 | Institution | 0.02% | 463,817 |
FAQ
Who Owns Amylyx Pharmaceuticals Inc (AMLX)?
Currently, no data Available
What percentage of Amylyx Pharmaceuticals Inc (AMLX) stock is held by institutional investors?
Currently, no data Available
What percentage of Amylyx Pharmaceuticals Inc (AMLX) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Amylyx Pharmaceuticals Inc (AMLX)?
Vanguard owns the most shares of Amylyx Pharmaceuticals Inc (AMLX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.